Cargando…
Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
AIMS/HYPOTHESIS: Diabetes is characterised by progressive loss of functional pancreatic beta cells. None of the therapeutic agents used to treat diabetes arrest this process; preventing beta cell loss remains a major unmet need. We have previously shown that serum from eight young healthy male parti...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676790/ https://www.ncbi.nlm.nih.gov/pubmed/36401627 http://dx.doi.org/10.1007/s00125-022-05837-9 |
_version_ | 1784833674289610752 |
---|---|
author | Coomans de Brachène, Alexandra Scoubeau, Corentin Musuaya, Anyïshai E. Costa-Junior, Jose Maria Castela, Angela Carpentier, Julie Faoro, Vitalie Klass, Malgorzata Cnop, Miriam Eizirik, Decio L. |
author_facet | Coomans de Brachène, Alexandra Scoubeau, Corentin Musuaya, Anyïshai E. Costa-Junior, Jose Maria Castela, Angela Carpentier, Julie Faoro, Vitalie Klass, Malgorzata Cnop, Miriam Eizirik, Decio L. |
author_sort | Coomans de Brachène, Alexandra |
collection | PubMed |
description | AIMS/HYPOTHESIS: Diabetes is characterised by progressive loss of functional pancreatic beta cells. None of the therapeutic agents used to treat diabetes arrest this process; preventing beta cell loss remains a major unmet need. We have previously shown that serum from eight young healthy male participants who exercised for 8 weeks protected human islets and insulin-producing EndoC-βH1 cells from apoptosis induced by proinflammatory cytokines or the endoplasmic reticulum (ER) stressor thapsigargin. Whether this protective effect is influenced by sex, age, training modality, ancestry or diabetes is unknown. METHODS: We enrolled 82 individuals, male or female, non-diabetic or diabetic, from different origins, in different supervised training protocols for 8–12 weeks (including training at home during the COVID-19 pandemic). EndoC-βH1 cells were treated with ‘exercised’ serum or with the exerkine clusterin to ascertain cytoprotection from ER stress. RESULTS: The exercise interventions were effective and improved [Formula: see text] values in both younger and older, non-obese and obese, non-diabetic and diabetic participants. Serum obtained after training conferred significant beta cell protection (28% to 35% protection after 4 and 8 weeks of training, respectively) from severe ER stress-induced apoptosis. Cytoprotection was not affected by the type of exercise training or participant age, sex, BMI or ancestry, and persisted for up to 2 months after the end of the training programme. Serum from exercised participants with type 1 or type 2 diabetes was similarly protective. Clusterin reproduced the beneficial effects of exercised sera. CONCLUSIONS/INTERPRETATION: These data uncover the unexpected potential to preserve beta cell health by exercise training, opening a new avenue to prevent or slow diabetes progression through humoral muscle–beta cell crosstalk. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-022-05837-9) contains peer-reviewed but unedited supplementary material.. |
format | Online Article Text |
id | pubmed-9676790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-96767902022-11-21 Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes Coomans de Brachène, Alexandra Scoubeau, Corentin Musuaya, Anyïshai E. Costa-Junior, Jose Maria Castela, Angela Carpentier, Julie Faoro, Vitalie Klass, Malgorzata Cnop, Miriam Eizirik, Decio L. Diabetologia Article AIMS/HYPOTHESIS: Diabetes is characterised by progressive loss of functional pancreatic beta cells. None of the therapeutic agents used to treat diabetes arrest this process; preventing beta cell loss remains a major unmet need. We have previously shown that serum from eight young healthy male participants who exercised for 8 weeks protected human islets and insulin-producing EndoC-βH1 cells from apoptosis induced by proinflammatory cytokines or the endoplasmic reticulum (ER) stressor thapsigargin. Whether this protective effect is influenced by sex, age, training modality, ancestry or diabetes is unknown. METHODS: We enrolled 82 individuals, male or female, non-diabetic or diabetic, from different origins, in different supervised training protocols for 8–12 weeks (including training at home during the COVID-19 pandemic). EndoC-βH1 cells were treated with ‘exercised’ serum or with the exerkine clusterin to ascertain cytoprotection from ER stress. RESULTS: The exercise interventions were effective and improved [Formula: see text] values in both younger and older, non-obese and obese, non-diabetic and diabetic participants. Serum obtained after training conferred significant beta cell protection (28% to 35% protection after 4 and 8 weeks of training, respectively) from severe ER stress-induced apoptosis. Cytoprotection was not affected by the type of exercise training or participant age, sex, BMI or ancestry, and persisted for up to 2 months after the end of the training programme. Serum from exercised participants with type 1 or type 2 diabetes was similarly protective. Clusterin reproduced the beneficial effects of exercised sera. CONCLUSIONS/INTERPRETATION: These data uncover the unexpected potential to preserve beta cell health by exercise training, opening a new avenue to prevent or slow diabetes progression through humoral muscle–beta cell crosstalk. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-022-05837-9) contains peer-reviewed but unedited supplementary material.. Springer Berlin Heidelberg 2022-11-19 2023 /pmc/articles/PMC9676790/ /pubmed/36401627 http://dx.doi.org/10.1007/s00125-022-05837-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Coomans de Brachène, Alexandra Scoubeau, Corentin Musuaya, Anyïshai E. Costa-Junior, Jose Maria Castela, Angela Carpentier, Julie Faoro, Vitalie Klass, Malgorzata Cnop, Miriam Eizirik, Decio L. Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes |
title | Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes |
title_full | Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes |
title_fullStr | Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes |
title_full_unstemmed | Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes |
title_short | Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes |
title_sort | exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676790/ https://www.ncbi.nlm.nih.gov/pubmed/36401627 http://dx.doi.org/10.1007/s00125-022-05837-9 |
work_keys_str_mv | AT coomansdebrachenealexandra exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT scoubeaucorentin exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT musuayaanyishaie exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT costajuniorjosemaria exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT castelaangela exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT carpentierjulie exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT faorovitalie exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT klassmalgorzata exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT cnopmiriam exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes AT eizirikdeciol exerciseasanonpharmacologicalinterventiontoprotectpancreaticbetacellsinindividualswithtype1andtype2diabetes |